Amarantus Therapeutics, Inc.
Records under this name other than patents Amarantus Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Amarantus Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,425 | Dopaminergic neuronal survival-promoting factors and uses thereof Lapsed on the fee record Ended Dec 27, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 27, 2019 | USPTO record |
| US 9,115,208 | Dopaminergic neuronal survival-promoting factors and uses thereof Lapsed on the fee record Ended Aug 25, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2019 | USPTO record |